AI-generated summary
This protocol describes a planned randomized, single-blind, multicenter trial comparing 650 nm invasive laser acupuncture with conventional electroacupuncture for pain in 90 patients with non-specific chronic low back pain. The authors report that the primary outcome will be the change in Visual Analog Scale pain score one week after treatment, and that the study is not yet completed. No results are reported.
- Participants
- 90
- Who or what was studied
- Patients with non-specific chronic low back pain
- Wavelengths
- 650 nm
- Limits stated in the abstract
- This is a trial protocol with no results reported, so efficacy and safety are not yet known.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
This study aims to evaluate the short-term efficacy of 650 nm invasive laser acupuncture (ILA) compared to conventional electroacupuncture (EA) in reducing pain in patients with non-specific chronic low back pain (NSCLBP).
Method
This is a prospective, multicenter, randomized, single-blind, controlled trial. Ninety patients with NSCLBP will be recruited and randomly assigned (1:1) to receive either 650 nm ILA or EA. Treatments will be administered at the bilateral acupoints BL23, BL24, BL25, and GB30 for 10 min per session, twice weekly for 4 weeks (8 sessions in total). The primary outcome is the change in the Visual Analog Scale (VAS) score 1 week after treatment completion. Secondary outcomes include VAS scores at interim and follow-up time points, Oswestry Disability Index, European Quality of Life Five Dimension Five-Level Scale, and the proportion of responders. Safety assessments and adverse event monitoring will be conducted throughout the trial.
Conclusion
This multicenter randomized controlled trial compares the effects of ILA and EA with the change in VAS as a primary efficacy endpoint in 90 patients with NSCLBP. This findings will provide clinical evidence of the comparative efficacy and safety of 650 nm ILA versus EA in patients with NSCLBP, supporting its potential as a viable non-pharmacological treatment option. CLINICAL
Trial Registration
https://cris.nih.go.kr/cris/search/detailSearch.do?search_lang=E&focus=reset_12&search_page=M&pageSize=10&page=undefined&seq=29960&status=5&seq_group=29960, identifier KCT0010475.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, Randomized controlled trial, Trial registration, Primary outcome, Adverse event. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.